Stellular Bio
PrivateLast Round
Series B
Nov 4, 2021
Total Funding Raised
$170.13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Stellular Bio is a biotechnology company that develops a platelet-derived regenerative biologic platform aimed at enhancing the treatment of patients with ocular surface disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stellular Bio Comparables
Compare Stellular Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Claris Bio | 81% | |
| Pandorum Technologies | 77% | |
| Cambium Bio | 77% | |
Stellular Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 4, 2021 | ||||
| Grant | Sep 30, 2019 | ||||
| Series A Extension | Sep 9, 2019 | ||||
| Series A | Jun 8, 2017 | ||||
| Seed | Jul 28, 2016 | ||||
Grant | Apr 1, 2016 |
Key People
Founding team and executive leadership
Stellular Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nest.Bio | Series A Extension |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| Oxford Finance | Series B |
| Ziff Capital Partners | Series B, Series A Extension |
| National Heart, Lung, and Blood Institute | Grant |
| Vivo Capital | Series A |
| K2 HealthVentures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 46% MoM.
- Sep 30, 2019
$56M grant awarded by Public Health Emergency Medical Countermeasures Enterprise.
Stellular Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Stellular Bio's valuation, stock price, and market status.